Ravindhiran Ramya, Dhandapani Kavitha
Department of Biochemistry, Biotechnology and Bioinformatics, Avinashilingam Institute for Home Science and Higher Education for Women, Coimbatore, 641043, India.
Department of Biochemistry, Biotechnology and Bioinformatics, Avinashilingam Institute for Home Science and Higher Education for Women, Coimbatore, 641043, India.
J Mol Graph Model. 2025 Nov;140:109123. doi: 10.1016/j.jmgm.2025.109123. Epub 2025 Jul 10.
Listeria monocytogenes is a causative agent for pernicious listeriosis outbreaks worldwide and it has attained more alertness due to the emergence of resistance and mortality rate. A transcriptional regulator (prfA) regulates all the virulence cascades in L. monocytogenes making it a unique and putative target for many drug molecules. Propolis, nature's hidden treasure, is a complex and heterogeneous mixture that contains many secondary metabolites of plant origin. Bees might produce some active compounds and harnessing their bioactive potential is a burgeoning interest to treat various illnesses. In this context, the present study focuses on evaluating the targeted action of the major bioactive compounds of propolis against the putative target (prfA) of L. monocytogenes. Among various propolis compounds, 75 ligands were selected and docked with the A chain of prfA. Initially, the pharmacokinetic properties of the ligands were evaluated using QikProp v_5.8 in the Schrodinger suite 2023_3. All the pharmacokinetic parameters were satisfied with the selected propolis compounds and the docking score of the compounds obtained was in the range of -13.022 to -5.171 kcal/mol. The compounds with high negative docking scores, such as Ligand 70 (-13.022 kcal/mol) and Ligand 39 (-12.58 kcal/mol) were subjected to molecular dynamics simulation studies to determine their binding stability for a 100 ns simulation course using Desmond v_5.6 packages embedded in the Maestro software v_11.8, followed by the binding free energies of the ligand-receptor complexes were computed using prime MM/GBSA. All the parameters have envisaged the stability of the ligand molecules at the active site of prfA (target protein) to inhibit L. monocytogenes pathogenicity in the host. In sum, the compounds of propolis synergistically act against L. monocytogenes by actively inhibiting the activity of transcriptional regulators (prfA) to combat listeriosis outbreaks, thus ensuring food safety and public health.
单核细胞增生李斯特菌是全球范围内恶性李斯特菌病爆发的病原体,由于耐药性和死亡率的出现,它已受到更多关注。一种转录调节因子(PrfA)调节单核细胞增生李斯特菌中的所有毒力级联反应,使其成为许多药物分子的独特且假定的靶点。蜂胶,大自然的隐藏宝藏,是一种复杂且异质的混合物,含有许多植物来源的次生代谢产物。蜜蜂可能会产生一些活性化合物,挖掘它们的生物活性潜力是治疗各种疾病的新兴研究热点。在此背景下,本研究重点评估蜂胶主要生物活性化合物对单核细胞增生李斯特菌假定靶点(PrfA)的靶向作用。在各种蜂胶化合物中,选择了75种配体并与PrfA的A链进行对接。最初,使用Schrodinger套件2023_3中的QikProp v_5.8评估配体的药代动力学性质。所选蜂胶化合物的所有药代动力学参数均符合要求,获得的化合物对接分数在-13.022至-5.171千卡/摩尔范围内。对接分数高负值的化合物,如配体70(-13.022千卡/摩尔)和配体39(-12.58千卡/摩尔),使用Maestro软件v_11.8中嵌入的Desmond v_5.6软件包进行100纳秒模拟过程的分子动力学模拟研究,以确定它们的结合稳定性,随后使用Prime MM/GBSA计算配体-受体复合物的结合自由能。所有参数都表明配体分子在PrfA(靶蛋白)活性位点的稳定性,以抑制宿主中单核细胞增生李斯特菌的致病性。总之,蜂胶化合物通过积极抑制转录调节因子(PrfA)的活性协同作用对抗单核细胞增生李斯特菌,以应对李斯特菌病爆发,从而确保食品安全和公众健康。